Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dih...
Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dihydrochloride
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Background
Metabolic reprogramming of energy processes is a cellular hallmark of various cancers. Whether trimetazidine, an anti-ischemic agent that preferentially potentiates cellular glucose oxidation, alters the long-term risk of malignancies is unknown.
Methods
In this multi-center, retrospective cohort study, we studied the effect of...
Alternative Titles
Full title
Long-term risk of malignancies in persons with ischemic heart disease treated with trimetazidine dihydrochloride
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_8cdb4a7b3586498a844e09a4671b4afc
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_8cdb4a7b3586498a844e09a4671b4afc
Other Identifiers
ISSN
2730-664X
E-ISSN
2730-664X
DOI
10.1038/s43856-025-00805-x
